

Attached herewith is the National Vaccination Operations Center Advisory No. 54 entitled “Guidance on the Vaccination of the Immediate Family Members of Healthcare Workers under Priority Group A1” and its Operational Guidance.
The COVID-19 pandemic has greatly challenged humanity and continues to do so. Unfortunately, these challenges are made more difficult for our healthcare workers at the frontlines of COVID-19 care. There are times when the mission and expertise of our frontline health providers are criticized and maligned. Oftentimes, our colleagues bear the cudgels for our health systems’ weaknesses, even as they do their utmost to care for COVID-19 patients and save lives.
We have all lost family members and loved ones in this pandemic. Our shared losses enhance our empathy with all the others who have also lost their loved ones to COVID- 19. The Philippine Society for Microbiology and Infectious Diseases (PSMID), a non-stock, non-profit association of healthcare professionals dedicated to saving lives and reducing the burden of infectious disease – especially against COVID-19, is not spared from the perils of this pandemic.
In these challenging times, there is the temptation to cast blame and aspersions on frontliners in the face of loss and grief, without fully understanding the context and rationale of holistic clinical management and care. We urge the community to focus against the real enemy, COVID-19. Divisiveness only serves to weaken and demotivate our health workforce. PSMID maintains an open communication line and a collaborative stance as we continue to lead and serve despite the risks and obstacles.
The PSMID expresses confidence in the expertise of its infectious disease clinicians. We stand by the competence, professional integrity, and clinical judgment of our infectious disease practitioners. We, as PSMID, always strive to provide holistic, evidence-based, and compassionate patient care, despite the challenges of a stretched and under- resourced health system and the risks to our own lives.
The PSMID deeply thank the countless women, men, organizations, and institutions who quietly serve and continue to provide support and encouragement to our healthcare workers. We hope for kindness. We hope for understanding. The spirit of unity and solidarity is what gives us hope that we can overcome the challenges that take a significant toll on our frontliners’ physical and mental health.
“YOU [WE] WILL ACHIEVE MORE IN THIS WORLD THROUGH ACTS OF MERCY THAN… THROUGH ACTS OF RETRIBUTION.” -Nelson Mandela
PSMID Board of Councils and Advisers 2021
Download the PSMID Statement of Solidarity with Frontline COVID-19 Health Providers here.
You may download the Covid-19 Vaccine Tracker document HERE.
You may download the PSMID Guidance on the Timing of Blood Donation among Donors Who Received COVID-19 Vaccines HERE.
Download the PSMID Statement on COVID-19 Vaccines and the Immunocompromised Host (ICH) here.
PSMID 42nd Annual Convention
The COVID-19 pandemic is a serious public health threat that continues to permeate all populations and sectors in the country, and the job sector is no exception. To protect the welfare of the Filipino workforce, the Department of Health (DOH), Department of Labor and Employment (DOLE), Department of Trade and Industry (DTI) together with the World Health Organization (WHO) and stakeholders from the different medical societies in the Philippines issue this handbook, which compiles essential information based on important issuances on COVID-19 prevention and management in the workplace. This hopes to provide proper guidance and appropriate information to all Occupational Safety and Health (OSH) Committees and other key stakeholders to empower them in ensuring that Filipino employees and workers everywhere in the country know how to protect themselves, their colleagues, and families from the threat of COVID-19.
Version 1 as of September 2020. This handbook will be updated as we compile the most recent evidence and policies relative to the workplace, as the COVID-19 pandemic progresses.
You may download the Workplace Handbook on COVID-19 Management and Prevention here.
Workplace Handbook -Version 1 _ Sept. 30-> NOTE: The COVID-19 Living Clinical Practice Guidelines contains UPDATED recommendations and evidence summaries. Click here to be redirected to the COVID LCPG.
This Interim Guidance on the Clinical Management of Adult Patients with Suspected or Confirmed COVID-19 Infection (Version 3.1) is an update of the March 31, 2020 guidelines released by the Philippine Society for Microbiology and Infectious Diseases. New evidence have been published since then necessitating this update.This document is written to guide clinicians and health care workers in their COVID-19 related management decisions. It is based on available scientific evidence that is also rapidly evolving, as more is discovered about the pathophysiology of SARS CoV-2 and the pathogenesis of the disease. As such, the recommendations in this guideline are based on limited, often low-quality evidence, and need to be carefully balanced with clinical judgment. The use of investigational drugs should be discussed with the patient or a legally authorized representative carefully outlining the potential adverse reactions and the potential clinical benefits of these investigational drugs. A signed informed consent should be obtained by the clinician.
DOWNLOAD the Interim Management Guidelines for COVID-19 (Version 3.1) here.
The performance of surgeries, especially elective surgeries, has been affected as healthcare facilities responded to the COVID-19 pandemic. However, surgery and other interventional procedures are invaluable aspects of healthcare even during disasters, mass casualty incidents, and even during pandemics. An organized and well-planned approach is needed to protect healthcare workers performing surgery and to rationally use available PPEs.
This document aims to provide guidance on how to assess the risk of COVID-19 transmission to the surgical team and recommend the necessary PPE to be used for every scenario. This is intended for surgeons, infectious disease specialists, internists and other physicians who will perform procedures or evaluate patients prior to such procedures. Other personnel involved in the surgical team might also find this document useful. Optimizing operating room infrastructure and other infection prevention and control measures are not within the scope of this document. Recommendations from this document may change as new evidence becomes available.
DOWNLOAD the Risk Assessment of Surgeries in the Context of COVID-19 document here.
PSMID-PHICS Guidelines for Risk Assessment of Surgeries during COVID19 26May2020Dr. Jemelyn Garcia, FPCP, FPSMID
Dr. Maria Sonia Salamat, FPCP, FPSMID
Dr. Marja B. Buensalido, FPCP, FPSMID
Dr. Emmerson Gale Vista, FPDS
Dr. Clarisse Garcia-Mendoza, FPDS
Dr. Kingbherly L. Li, FPCP, FPSMID
Dr. Yvette Silubrico, FPCP, FPSMID
Dr. Chatie Olasiman, FPCP, FPSMID
Dr. Ma. Charmian Hufano, FPCP, FPSMID
Dr. Mitzie Lou Osabel, FPCP, FPSMID
Dr. Janice C. Caoili, FPCP, FPSMID
The Philippine Society for Microbiology and Infectious Diseases (PSMID) Guidance on the Management of Mpox, Ver. 1 provides the basic and most updated information on management of patients confirmed with mpox.
This guidance complements the mpox recommendations of the DOH (Updated Interim Guidelines on the Prevention, Detection, and Management of MPOX, by Department of Health, August 26, 2024, Department Memorandum 2024-0306) and PHICS-PHICNA (Interim Guidelines on the Prevention and Control of Monkeypox version 1).
The antivirals, immunoglobulin and vaccines discussed below are not available locally. In our local situation, we should maximize supportive care for mpox cases.